The aim of this study was to evaluate the analytical performance of a recently available immunoassay for brain natriuretic peptide (BNP), based on microparticle enzyme immunoassay (MEIA, AxSYM System, Abbott Laboratories), whose analytical characteristics and clinical results were compared with those of a point of care testing (POCT) method (TRIAGE system, Biosite Diagnostics)...
Keywords: brain natriuretic peptide, cardiac natriuretic hormones, Heart failure, microparticle enzyme immunoassay system, point of care testing method
10/2004 | Clinical Chemical Laboratory Medicine, Walter de Gruyter